BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26580980)

  • 1. Design of α7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.
    Ouach A; Pin F; Bertrand E; Vercouillie J; Gulhan Z; Mothes C; Deloye JB; Guilloteau D; Suzenet F; Chalon S; Routier S
    Eur J Med Chem; 2016 Jan; 107():153-64. PubMed ID: 26580980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bis(het)aryl-1,2,3-triazole quinuclidines as α7 nicotinic acetylcholine receptor ligands: Synthesis, structure affinity relationships, agonism activity, [
    Ouach A; Vercouillie J; Bertrand E; Rodrigues N; Pin F; Serriere S; Boiaryna L; Chartier A; Percina N; Tangpong P; Gulhan Z; Mothes C; Deloye JB; Guilloteau D; Page G; Suzenet F; Buron F; Chalon S; Routier S
    Eur J Med Chem; 2019 Oct; 179():449-469. PubMed ID: 31271958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.
    Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P
    ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates.
    Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P
    Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of α7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [(18)F] quinuclidine derivative.
    Pin F; Vercouillie J; Ouach A; Mavel S; Gulhan Z; Chicheri G; Jarry C; Massip S; Deloye JB; Guilloteau D; Suzenet F; Chalon S; Routier S
    Eur J Med Chem; 2014 Jul; 82():214-24. PubMed ID: 24904968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of multifunctional ligands targeting acetylcholinesterase and alpha 7 nicotinic acetylcholine receptor.
    Cieslikiewicz-Bouet M; Naldi M; Bartolini M; Pérez B; Servent D; Jean L; Aráoz R; Renard PY
    Biochem Pharmacol; 2020 Jul; 177():114010. PubMed ID: 32360492
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Arunrungvichian K; Chongruchiroj S; Sarasamkan J; Schüürmann G; Brust P; Vajragupta O
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective α
    Kanasuwan A; Deuther-Conrad W; Chongruchiroj S; Sarasamkan J; Chotipanich C; Vajragupta O; Arunrungvichian K
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of phenylcarbamate derivatives as ligands for nicotinic acetylcholine receptors.
    Gündisch D; Andrä M; Munoz L; Cristina Tilotta M
    Bioorg Med Chem; 2004 Sep; 12(18):4953-62. PubMed ID: 15336274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation.
    Pismataro MC; Horenstein NA; Stokes C; Quadri M; De Amici M; Papke RL; Dallanoce C
    Eur J Med Chem; 2020 Nov; 205():112669. PubMed ID: 32810771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptor.
    Nencini A; Castaldo C; Comery TA; Dunlop J; Genesio E; Ghiron C; Haydar S; Maccari L; Micco I; Turlizzi E; Zanaletti R; Zhang J
    Eur J Med Chem; 2014 May; 78():401-18. PubMed ID: 24704613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors.
    Deligia F; Deiana V; Gotti C; Lazzari P; Bottazzi ME; Pucci L; Fasoli F; Ragusa G; Pinna GA; Murineddu G
    Eur J Med Chem; 2015 Oct; 103():429-37. PubMed ID: 26383127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α7-Nicotinic acetylcholine receptor antagonist QND7 suppresses non-small cell lung cancer cell proliferation and migration via inhibition of Akt/mTOR signaling.
    Witayateeraporn W; Arunrungvichian K; Pothongsrisit S; Doungchawee J; Vajragupta O; Pongrakhananon V
    Biochem Biophys Res Commun; 2020 Jan; 521(4):977-983. PubMed ID: 31727368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological activities of piperidine-spirooxadiazole derivatives as α7 nicotinic receptor antagonists.
    Zhang H; He X; Wang X; Yu B; Zhao S; Jiao P; Jin H; Liu Z; Wang K; Zhang L; Zhang L
    Eur J Med Chem; 2020 Dec; 207():112774. PubMed ID: 32882607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Functional Evaluation of a Novel Series of Phosphonate-Functionalized 1,2,3-Triazoles as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors.
    Nielsen BE; Stabile S; Vitale C; Bouzat C
    ACS Chem Neurosci; 2020 Sep; 11(17):2688-2704. PubMed ID: 32786318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.
    Bodnar AL; Cortes-Burgos LA; Cook KK; Dinh DM; Groppi VE; Hajos M; Higdon NR; Hoffmann WE; Hurst RS; Myers JK; Rogers BN; Wall TM; Wolfe ML; Wong E
    J Med Chem; 2005 Feb; 48(4):905-8. PubMed ID: 15715459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminobenzisoxazole compounds as agonists of α7 nicotinic acetylcholine receptors: a patent evaluation (WO 2017027600).
    He Y; Shen J
    Expert Opin Ther Pat; 2018 May; 28(5):429-436. PubMed ID: 29566578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varying Chirality Across Nicotinic Acetylcholine Receptor Subtypes: Selective Binding of Quinuclidine Triazole Compounds.
    Sarasamkan J; Scheunemann M; Apaijai N; Palee S; Parichatikanond W; Arunrungvichian K; Fischer S; Chattipakorn S; Deuther-Conrad W; Schüürmann G; Brust P; Vajragupta O
    ACS Med Chem Lett; 2016 Oct; 7(10):890-895. PubMed ID: 27774124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand.
    Teodoro R; Scheunemann M; Deuther-Conrad W; Wenzel B; Fasoli FM; Gotti C; Kranz M; Donat CK; Patt M; Hillmer A; Zheng MQ; Peters D; Steinbach J; Sabri O; Huang Y; Brust P
    Molecules; 2015 Oct; 20(10):18387-421. PubMed ID: 26473809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.